Robert Ho Neoleukin Therapeutics, Inc. (NLTX) insider trading activity

NLTX Quotes by TradingView

Robert Ho is Chief Financial Officer of Neoleukin Therapeutics, Inc.. Currently has a direct ownership of 21,503 shares of NLTX, which is worth approximately $0. The most recent transaction as insider was on Mar 17, 2021, when has been sold 6,497 shares (Common Stock) at a price of $11.01 per share, resulting in proceeds of $71,532. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.5K
0% 3M change
0% 12M change
Total Value Held $0

Robert Ho Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2021
SELL
Open market or private sale
$71,532 $11.01 p/Share
6,497 Reduced 23.2%
21,503 Common Stock
Mar 16 2021
BUY
Exercise of conversion of derivative security
-
25,000 Added 47.17%
28,000 Common Stock

Also insider at

THRD
Third Harmonic Bio, Inc. Healthcare
Chief Financial Officer
RH

Robert Ho

Chief Financial Officer
Seattle, WA

Track Institutional and Insider Activities on NLTX

Follow Neoleukin Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NLTX shares.

Notify only if

Insider Trading

Get notified when an Neoleukin Therapeutics, Inc. insider buys or sells NLTX shares.

Notify only if

News

Receive news related to Neoleukin Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NLTX